Assessment of the clinical usefulness of nebulised ipratropium bromide in patients with chronic airflow limitation.-Reference-Cited by-同舟云学术

Assessment of the clinical usefulness of nebulised ipratropium bromide in patients with chronic airflow limitation.

Published:1984-04-01 Issue:4 Volume:39 Page:272-276
ISSN:0040-6376
Container-title:Thorax
language:en
Short-container-title:Thorax

Author:

Brown I G,Chan C S,Kelly C A,Dent A G,Zimmerman P V

Publisher

BMJ

Subject

Pulmonary and Respiratory Medicine

Reference15 articles.

1. Physiol: Respirat Environ Exercise;Physiol,1979

2. Comparison of ipratropium bromide and fenoterol in asthma and chronic bronchitis;Marlin, G.E.; Bush, D.E.; Berend, N.;Br J Clin Pharmacol,1978

3. Ipratropium bromide: A review of its pharmacological properties and therapeutic efficacy in asthma and chronic bronchitis;Pakes, G.E.; Brogden, R.N.; Heel, R.C.; Speight, T.M.; Avery, C.S.,1980

4. Bronchodilator action of the anticholinergic drug, ipratropium bromide (Sch 1000), as an aerosol in chronic bronchitis and asthma;Baigelman, W.; Chodosh, S.;Chest,1977

5. Bronchodilatation and the site of airways resistance in severe chronic bronchitis;Douglas, N.J.; Davidson, I.; Sudlow, M.F.; Flenley, D.C.;Thorax,1979

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relative and Additional Bronchodilator Response of Salbutamol and Ipratropium in Smoker and Nonsmoker Asthmatics;Journal of Asthma;2010-04

2. Ipratropium bromide versus long-acting beta-2 agonists for stable chronic obstructive pulmonary disease;Cochrane Database of Systematic Reviews;2006-07-19

3. Ipratropium bromide versus short acting beta-2 agonists for stable chronic obstructive pulmonary disease;Cochrane Database of Systematic Reviews;2006-04-19

4. Anticholinergic agents in asthma and COPD;European Journal of Pharmacology;2006-03

5. Ipratropium bromide versus short acting beta-2 agonists for stable chronic obstructive pulmonary disease;COCHRANE DB SYST REV;2006